Market Closed -
Nasdaq
02:00:00 04/05/2024 am IST
5-day change
1st Jan Change
21.5
USD
+1.22%
+6.97%
-25.63%
Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell Microcap Growth Index
June 25, 2021 at 09:30 am IST
Fulgent Genetics, Inc.(NasdaqGM:FLGT) dropped from Russell Microcap Growth Index
Transcript : Fulgent Genetics, Inc., Q1 2024 Earnings Call, May 03, 2024
03/05
Earnings Flash (FLGT) FULGENT GENETICS Posts Q1 Revenue $64.5M
03/05
MT
Fulgent Genetics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
03/05
CI
Piper Sandler Adjusts Price Target on Fulgent Genetics to $25 From $28, Maintains Neutral Rating
06/03
MT
UBS Adjusts Fulgent Genetics Price Target to $25 From $35, Maintains Neutral Rating
29/02
MT
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.
29/02
CI
Fulgent Genetics, Inc. Provides Earnings Guidance for the Year 2024
28/02
CI
Transcript : Fulgent Genetics, Inc., Q4 2023 Earnings Call, Feb 28, 2024
28/02
Fulgent Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
28/02
CI
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 Revenue $70.5M
28/02
MT
Earnings Flash (FLGT) FULGENT GENETICS Reports Q4 EPS $0.28
28/02
MT
Cooper Unit, Fulgent Genetic to Offer Newborn Genetic Screening Panels
09/02
MT
Cord Blood Registry by CooperSurgical, Inc. and Fulgent Genetics, Inc. Launch Innovative Genetic Testing
09/02
CI
UBS Initiates Coverage on Fulgent Genetics With Neutral Rating, $35 Price Target
07/12
MT
Fulgent Genetics, Inc. Announces Two Poster Presentations At SITC 2023 Annual Meeting
04/11
CI
Transcript : Fulgent Genetics, Inc., Q3 2023 Earnings Call, Nov 03, 2023
03/11
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.
03/11
CI
Fulgent Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
03/11
CI
Fulgent Genetics, Inc. Reiterates Earnings Guidance for the Full Year 2023
03/11
CI
Insider Sell: Fulgent Genetics
31/23/31
MT
Sector Update: Health Care Stocks Steady Premarket Friday
04/23/04
MT
Transcript : Fulgent Genetics, Inc., Q2 2023 Earnings Call, Aug 04, 2023
04/23/04
Fulgent Genetics Swings to Loss in Q2, Revenue Declines; Raises Guidance; Shares Surge 10% Pre-Bell
04/23/04
MT
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022.
04/23/04
CI
Fulgent Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
04/23/04
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Companyâs laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.
More about the company
Last Close Price
21.5
USD
Average target price
26.67
USD
Spread / Average Target
+24.03%
Consensus
1st Jan change
Capi.
-25.63% 643M -17.92% 8.3B -8.58% 2.47B -38.71% 2.46B -9.98% 2.31B -5.44% 1.95B -17.79% 1.59B -40.78% 1.21B +6.69% 1.1B -29.22% 931M
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1